Welcome to our dedicated page for Tenon Medical SEC filings (Ticker: TNONW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Tenon Medical's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Tenon Medical's regulatory disclosures and financial reporting.
Tenon Medical, Inc. filed an 8-K dated September 23, 2025 that lists its publicly traded securities and records signatures and share-count figures for several named officers and directors. The document references Common Stock (par value $0.001) trading under the symbol TNON and Warrants trading under TNONW on The Nasdaq Stock Market. Individual entries show numeric holdings for Steven Foster, Richard Ginn, Stephen Hochschuler, MD, Ivan Howard, Kristine Jacques, and Robert Weigle, and the filing is executed by Steven M. Foster in his capacity as Chief Executive Officer and President.
Tenon Medical, Inc. has rescheduled its previously adjourned Annual Meeting to be held virtually on September 18, 2025, at 10:30 a.m. Pacific Time. The meeting had been adjourned on July 23, 2025 and August 20, 2025.
Only shareholders of record at the close of business on August 22, 2025 are entitled to notice and to vote. Stockholders must use a Virtual Control Number to participate and vote electronically, with additional steps required for those holding shares in “street name.” The company urges shareholders to vote before September 16, 2025 to ensure their votes are received and counted.